-
EP0813424
European procedure
Extract from the Register of European Patents
EP About this file: EP0813424
| EP0813424 - ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND AN ANTACID AGENT OR ALGINATE [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 03.07.2009 Database last updated on 29.10.2024 | Most recent event Tooltip | 17.04.2015 | Change - lapse in a contracting state | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2000/19] |
| Former [1997/52] | For all designated states Astra Aktiebolag 151 85 Södertälje / SE | Inventor(s) | 01 /
DEPUI, Helene Wrangelsgatan 7B S-416 62 Göteborg / SE | 02 /
HALLGREN, Agneta Hökegärdsgatan 2C S-431 38 Mölndal / SE | [2002/47] |
| Former [1997/52] | 01 /
DEPUI, Helene Wrangelsgatan 7B S-416 62 Göteborg / SE | ||
| 02 /
HALLGREN, Agneta Hökeg rdsgatan 2C S-431 38 Mölndal / SE | Application number, filing date | 96944726.7 | 20.12.1996 | [1997/52] | WO1996SE01737 | Priority number, date | SE19960000071 | 08.01.1996 Original published format: SE 9600071 | [1997/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9725066 | Date: | 17.07.1997 | Language: | EN | [1997/31] | Type: | A1 Application with search report | No.: | EP0813424 | Date: | 29.12.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.07.1997 takes the place of the publication of the European patent application. | [1997/52] | Type: | B1 Patent specification | No.: | EP0813424 | Date: | 20.11.2002 | Language: | EN | [2002/47] | Type: | B2 New European patent specification | No.: | EP0813424 | Date: | 05.08.2009 | Language: | EN | [2009/32] | Search report(s) | International search report - published on: | SE | 17.07.1997 | Classification | IPC: | A61K45/06, A61K31/44, A61K33/08, A61K33/10, A61K9/20, A61K9/26, A61P1/04 | [2002/01] | CPC data not yet available |
| Former IPC [1997/52] | A61K45/06, A61K31/44, A61K33/08, A61K33/10, A61K9/20, A61K9/26 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/52] | Extension states | LT | 08.10.1997 | LV | 08.10.1997 | RO | 08.10.1997 | SI | 08.10.1997 | Title | German: | ORALE, PHARMAZEUTISCHE DARREICHUNGSFORMEN, DIE EINEN PROTONENPUMPENINHIBITOR UND EIN ANTACIDUM ODER ALGINAT ENTHALTEN | [2002/01] | English: | ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND AN ANTACID AGENT OR ALGINATE | [1997/52] | French: | FORMES GALENIQUES PAR VOIE ORALE COMPRENANTS UN INHIBITEUR DE LA POMPE A PROTONS ET UN AGENT ANTACIDE OU UN ALGINATE | [2002/01] |
| Former [1997/52] | ORALE, PHARMAZEUTISCHE DARREICHUNGSFORMEN DIE EINE PROTONENPUMPENINHIBITOR UND EINEN ANTACIDA ODER ALGINAT ENTHÄLTEN | ||
| Former [1997/52] | FORMES GALENIQUES PAR VOIE ORALE COMPRENANT UN INHIBITEUR DE LA POMPE A PROTONS ET UN AGENT ANTIACIDE OU UN ALGINATE | Entry into regional phase | 08.10.1997 | National basic fee paid | 08.10.1997 | Designation fee(s) paid | 19.01.1998 | Examination fee paid | Examination procedure | 19.01.1998 | Examination requested [1998/12] | 19.02.2001 | Despatch of a communication from the examining division (Time limit: M04) | 19.06.2001 | Reply to a communication from the examining division | 10.08.2001 | Despatch of a communication from the examining division (Time limit: M04) | 23.10.2001 | Reply to a communication from the examining division | 23.11.2001 | Despatch of communication of intention to grant (Approval: No) | 22.03.2002 | Despatch of communication of intention to grant (Approval: later approval) | 22.07.2002 | Communication of intention to grant the patent | 22.08.2002 | Fee for grant paid | 22.08.2002 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
07.08.2003
22.09.2003
ADMISSIBLE Reckitt Benckiser Healthcare (UK) Limited 103-105 Bath Road Slough Bershire SL1 3UH / GB Opponent's representative Brierley, Anthony Paul, et al, et al Appleyard Lees 15 Clare Road Halifax HX1 2HY / GB | [N/P] |
| Former [2006/44] | |||
| Opponent(s) | 01
07.08.2003
22.09.2003
ADMISSIBLE Reckitt Benckiser Healthcare (UK) Limited 103-105 Bath Road Slough Bershire SL1 3UH / GB Opponent's representative Brierley, Anthony Paul, et al, et al Appleyard Lees 15 Clare Road GB-Halifax, West Yorkshire HX1 2HY / GB | ||
| Former [2005/18] | |||
| Opponent(s) | 01
07.08.2003
22.09.2003
ADMISSIBLE Reckitt Benckiser Healthcare (UK) Limited 103-105 Bath Road Slough Bershire SL1 3UH / GB Opponent's representative Instone, Terry, et al, et al Reckitt Benckiser plc, Intellectual Property Department - Patents Group, Dansom Lane Hull HU8 7DS / GB | ||
| Former [2003/40] | |||
| Opponent(s) | 01
07.08.2003
22.09.2003
ADMISSIBLE Reckitt Benckiser (UK) Limited 103-105 Bath Road Slough Berks SL1 3UH / GB Opponent's representative Hall, Marina, et al, et al Reckitt Benckiser plc, Group Patents Department, Dansom Lane Hull HU8 7DS / GB | 25.09.2003 | Invitation to proprietor to file observations on the notice of opposition | 31.03.2004 | Reply of patent proprietor to notice(s) of opposition | 10.05.2005 | Date of oral proceedings | 06.06.2005 | Despatch of minutes of oral proceedings | 18.12.2006 | Despatch of a communication from the opposition division (Time limit: M06) | 25.06.2007 | Reply to a communication from the opposition division | 12.06.2008 | Despatch of a communication from the opposition division (Time limit: M02) | 21.08.2008 | Reply to a communication from the opposition division | 14.11.2008 | Despatch of interlocutory decision in opposition | 24.11.2008 | Legal effect of interlocutory decision in opposition | 10.03.2009 | Despatch of communication that the patent will be maintained as amended | 22.06.2009 | Fee for printing new specification paid | Appeal following opposition | 28.06.2005 | Appeal received No. T0811/05 | 04.10.2005 | Statement of grounds filed | 19.10.2006 | Result of appeal procedure: continuation of opposition procedure | 19.10.2006 | Date of oral proceedings | 26.10.2006 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 04.01.1999 | Renewal fee patent year 03 | 05.01.2000 | Renewal fee patent year 04 | 02.01.2001 | Renewal fee patent year 05 | 02.01.2002 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2003/20] | GR | 20.11.2002 | Cited in | International search | [A]EP0247983 (HAESSLE AB [SE]); | [X]EP0338861 (WALTON SA [ES]); | [A]EP0365947 (PHARMACIA AB [SE]); | [X]US5244670 (UPSON JAMES G [US], et al); | [A] - TAKEUCHI K. ET AL., "Healing Process of Duodenal Ulcers Induced by Indomethacin Plus Histamine in Rats", CAPLUS, Database accession no. 1989:490176, XP002988505 | [ ] - DIGESTION, (1989), vol. 42, no. 4, pages 202 - 211 | Examination | - STN INTERNATIONAL, File CAPLUS, CAPLUS Accession No. 1989:490176, K. TAKEUCHI et al., "Healing Process of Duodenal Ulcers Induced by Indomethacin Plus Histamine in Rats"; & DIGESTION, (1989), 42(4), 202-11. | Opposition | JP2013706495 | EP0290229 | EP0294933 | EP0391518 | EP0290229 | EP0294933 | EP0496437 | WO9321932 | EP0600725 | WO9501780 | WO9510264 | EP0496437 | EP0723777 | EP0761212 | EP0600725 | - A. SANDBERG ET AL., EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, (1988), vol. 33, pages 53 - 57 | - J.-P. DECHESNE, INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1987), vol. 37, pages 203 - 209 | - P. LINDBERG ET AL., MEDICAL RESEARCH REVIEWS, (1990), vol. 10, no. 1, pages 1 - 54 | - H.A.R.E. TUYNMAN ET AL., BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (1987), vol. 24, pages 833 - 835 |